Abstract
Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Current Genomics
Title: Bioengineered Crops: The Commercial and Ethical Considerations
Volume: 2 Issue: 2
Author(s): Susmita Sengupta, L. K. Sengupta and P. S. Bisen
Affiliation:
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Abstract: Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Export Options
About this article
Cite this article as:
Sengupta Susmita, Sengupta K. L. and Bisen S. P., Bioengineered Crops: The Commercial and Ethical Considerations, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013351011
DOI https://dx.doi.org/10.2174/1389202013351011 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Methods for Biomarker Verification and Assay Development
Current Proteomics Recent Advances in Two-Photon Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines
CNS & Neurological Disorders - Drug Targets Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss
Endocrine, Metabolic & Immune Disorders - Drug Targets Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Current Pharmaceutical Design Quantum Dots in the Therapy: Current Trends and Perspectives
Mini-Reviews in Medicinal Chemistry The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Progress in Gene Delivery by Cationic Lipids : Guanidinium-Cholesterol-Based Systems as an Example
Current Drug Targets Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)]
Current Pharmaceutical Design A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Gallic Acid-Phospholipid Complex: Drug Incorporation and Physicochemical Characterization
Letters in Drug Design & Discovery Green Reduction of Graphene Oxide into Graphene by Cow Urine
Current Nanomaterials Gold Nanostructures as Photothermal Therapy Agent for Cancer
Anti-Cancer Agents in Medicinal Chemistry The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy
Current Topics in Medicinal Chemistry Antisense Technology: A Selective Tool for Gene Expression Regulation and Gene Targeting
Current Pharmaceutical Biotechnology MEMS and Microfluidics for Diagnostics Devices
Current Pharmaceutical Biotechnology Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond
Clinical Cancer Drugs Cell-penetrating Peptide-based Intelligent Liposomal Systems for Enhanced Drug Delivery
Current Pharmaceutical Biotechnology Utility of Limited Sampling Strategies for Anticancer Agents in the Clinical Arena: A Systematic Review
Current Cancer Therapy Reviews